Aprogen Biologics Market Cap

Aprogen Biologics has a market cap or net worth of 49.59 billion as of April 29, 2026. Its market cap has decreased by -67.44% in one year.

Market Cap

49.59B

Enterprise Value

296.56B

Revenue

73.23B

Ranking

n/a

PE Ratio

n/a

Stock Price

251.00

Market Cap Chart

Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 49.59B, an increase of 1,460.76%. That is a compound annual growth rate of 9.50%.

Market Cap History

Date	Market Cap	% Change
Apr 10, 2026	49.59B	-51.64%
Dec 30, 2025	102.54B	-21.60%
Dec 30, 2024	130.79B	-31.41%
Dec 28, 2023	190.68B	-4.89%
Dec 29, 2022	200.48B	-44.42%
Dec 30, 2021	360.71B	-31.18%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MYUNGMOON Pharm co.,Ltd	60.00B
Yuyu Pharma	68.19B
Enzychem Lifesciences	76.86B
Kukje Pharma	96.93B
Dong Sung Bio Pharm.Co.,Ltd.	23.24B
CKD Bio	109.28B
Ildong Holdings	114.73B
HANDOK	135.63B

Market Cap Rankings